Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity

Irit Ben Aharon; Hadas Bar Joseph; Moran Tzabari; Boris Shenkman; Nahid Farzam; Mattan Levi; Ruth Shalgi; Salomon M. Stemmer; Naphtali Savion

doi:10.1371/journal.pone.0075157

Loading metrics

Open Access

Peer-reviewed

Research Article

Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity

Irit Ben Aharon ,

* E-mail: iritbenaharon@gmail.com

Affiliation Institute of Oncology, Davidoff Center and Rabin Medical Center, Petah-Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Hadas Bar Joseph,

Affiliation Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Moran Tzabari,

Affiliation Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Boris Shenkman,

Affiliation Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel
⨯
Nahid Farzam,

Affiliation Goldschleger Eye Research Institute and Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Mattan Levi,

Affiliation Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Ruth Shalgi,

Affiliation Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Salomon M. Stemmer,

Affiliation Institute of Oncology, Davidoff Center and Rabin Medical Center, Petah-Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Naphtali Savion

Affiliation Goldschleger Eye Research Institute and Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯

Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity

Irit Ben Aharon,
Hadas Bar Joseph,
Moran Tzabari,
Boris Shenkman,
Nahid Farzam,
Mattan Levi,
Ruth Shalgi,
Salomon M. Stemmer,
Naphtali Savion

Published: September 20, 2013
https://doi.org/10.1371/journal.pone.0075157

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.
Blood flow
Is the Subject Area "Blood flow" applicable to this article?

Thanks for your feedback.
Platelet aggregation
Is the Subject Area "Platelet aggregation" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Toxic agents
Is the Subject Area "Toxic agents" applicable to this article?

Thanks for your feedback.